Toward Excellence in Testosterone Testing: A Consensus Statement

Introduction:  Even though testosterone assays are commonly used, they have deficiencies, making it difficult to broadly and effectively rely upon the assays in patient care.  These deficiencies are a threat to effective care for them.

Testosterone assays—both research and clinical—need to be held to a higher standard if the medical community wants to move forward in translating research results into more effective patient care, including the creation of evidence-based guidelines.

To address this issue, a group of stakeholders met.

Methods:  The stakeholders represented various professional societies.  They also came from the government sector and industry.  All participants would like to see testosterone levels more accurately and reliably measured.  In their meeting, they worked to identify the goals, objectives, and actions needed to achieve testosterone assay standardization.

Results:  The group agreed on several recommendations.  These include:

They suggest these goals be met by 2012—with a review every 2 to 4 years after that in order to assure accuracy.

Commentary by Glenn R. Cunningham MD